Lindbrook Capital, LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,793
+7.9%
1170.0%0.00%0.0%
Q2 2023$6,298
+35.5%
1170.0%0.00%0.0%
Q1 2023$4,647
-7.6%
117
-6.4%
0.00%0.0%
Q4 2022$5,029
+25.7%
1250.0%0.00%0.0%
Q3 2022$4,0000.0%1250.0%0.00%0.0%
Q2 2022$4,000
+33.3%
125
+13.6%
0.00%
Q1 2022$3,000
-81.2%
110
-45.0%
0.00%
-100.0%
Q2 2019$16,0002000.01%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders